CDx Diagnostics® Email Format

Medical and Diagnostic LaboratoriesNew York, United States51-200 Employees

CDx Diagnostics is a mid-sized medical and diagnostic laboratory based in Suffern, New York. It has developed a proprietary platform that combines imaging, artificial intelligence, molecular biology, and advanced tissue analysis to detect precancerous changes earlier and more reliably than conventional methods. The company emphasizes that its tests are designed for rapid adoption in clinical practice and are positioned to be cost-effective within typical reimbursement frameworks.

Its primary customers are clinicians and endoscopists who oversee cancer prevention and surveillance programs, with a focus on detecting precancerous conditions such as Barrett's esophagus and related dysplasia. WATS3D is a key offering that enables broader tissue sampling and AI-assisted interpretation to improve detection rates while work continues to extend its use to other GI sites. In 2025, CDx announced that new clinical data supporting the utility of WATS3D for Barrett's esophagus and dysplasia were selected for podium presentation at Digestive Disease Week in San Diego.

Sign up for free to view info

Company overview Employee directory